Target intelligence / Profile preview

Glutathione transport and uptake machinery

Molecular classification
Transporter, Enzyme, Solute carrier, ABC transporter
01

Overview

The glutathione transport and uptake machinery is a coordinated system of membrane transporters and enzymes that maintain cellular and systemic glutathione (GSH) homeostasis. This machinery primarily includes the cystine/glutamate antiporter (SLC7A11/xCT), which imports the rate-limiting precursor cystine for intracellular GSH synthesis, and multidrug resistance-associated proteins (such as ABCC1/MRP1), which facilitate the efflux of GSH, its oxidized form (GSSG), and GSH-xenobiotic conjugates. Additionally, the cell-surface enzyme gamma-glutamyltransferase (GGT1) initiates the breakdown of extracellular GSH, allowing for the salvage of its constituent amino acids. This system is vital for protecting cells against oxidative stress, regulating ferroptosis, and detoxifying xenobiotics. In cancer, the upregulation of these components often leads to chemoresistance and evasion of cell death, making them significant therapeutic targets. Conversely, dysfunction in this machinery is associated with neurodegenerative diseases and chronic inflammation. Pharmacological modulation includes inhibitors of SLC7A11, such as erastin and sulfasalazine, to induce ferroptosis, and MRP inhibitors like MK-571 to sensitize tumors to chemotherapy.

Other names
Glutathione transport systemGSH transport machineryGamma-glutamyl cycleSystem xC-MRP-mediated exportSLC7A11/ABCC1/GGT1 system
02

Mechanism of action

Inhibition of cystine/glutamate exchange (SLC7A11), inhibition of ATP-dependent glutathione efflux (MRPs), and inhibition of gamma-glutamyl bond cleavage (GGT1) to modulate intracellular glutathione levels and redox state.

03

Biological functions

Redox homeostasisDetoxificationFerroptosis regulationAmino acid metabolismOxidative stress response
04

Disease associations

CancerNeurodegenerative diseaseInflammationCardiovascular diseaseInfection
05

Safety considerations

Systemic oxidative stress [1.2.1]NephrotoxicityImpaired detoxification of xenobioticsDisruption of glutamate signaling
06

Interacting drugs

Erastin

6 more in the full profile.

07

Biomarkers

SLC7A11 expression [1.3.1]GGT1 activityGSH:GSSG ratioMalondialdehyde (MDA)4-Hydroxynonenal (4-HNE)

Beyond the preview

Go deeper on Glutathione transport and uptake machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutathione transport and uptake machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call